National Kidney Foundation's Innovation Fund Invests in Klinrisk to Revolutionize Chronic Kidney Disease Care
Summary
NEW YORK, June 12, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is proud to announce its latest investment through the NKFs Innovation Fund in Klinrisk, an artificial intelligence-based medical device company. These models enable healthcare professionals to intervene at the earliest stages of the disease, preventing a lifetime of dialysis and transforming patient outcomes. By investing in Klinrisks groundbreaking technologies, the NKFs Innovation Fund aims to accelerate the adoption of risk-based care models and ensure that effective interventions are deployed at the earliest possible stage, particularly among underserved populations. "We now have an abundance of effective therapeutics that can slow CKD progression and prevent cardiovascular events, yet they are not reaching the majority of patients until very late in the journey. "With the support of the NKFs Innovation Fund, Klinrisk will further enhance its predictive models and expand their implementation across healthcare systems.